Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam

Durlobactam is a new member of the diazabicyclooctane class of β-lactamase inhibitors with broad spectrum activity against Ambler class A, C, and D serine β-lactamases. Sulbactam is a first generation β-lactamase inhibitor with activity limited to a subset of class A enzymes that also has direct-act...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Microbiol
Autors principals: Shapiro, Adam B., Moussa, Samir H., McLeod, Sarah M., Durand-Réville, Thomas, Miller, Alita A.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Microbiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8328114/
https://ncbi.nlm.nih.gov/pubmed/34349751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2021.709974
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars